ask why

Latest research

Every new paper in 280 characters, with how strong the evidence is and what readers question about it. Free to read.

Gastroenterology · J Crohns Colitis · 2026-08-05

Network meta-analysis of 16 retrospective cohort studies (3235 UC patients having colorectal surgery): preoperative ustekinumab (RR 0.29) and tofacitinib (RR 0.66) were associated with fewer 30-day complications than no advanced therapy; anti-TNF with more at 90 days (RR 1.20).

Meta-analysisn = 3,235
Hayek et al. Comparative risk of postoperative complications in ulcerative colitis patients following preoperative advanced therapies: a network meta-analysis with meta-regression
Gastroenterology · J Crohns Colitis · 2026-05-08

Systematic review of 49 studies (mostly case reports and series) of non-anti-TNF advanced therapies in pregnancy for immune-mediated inflammatory diseases: pooled rates were 0.55% major malformations and 8.16% miscarriage, with no differences vs anti-TNFs; evidence very low.

Meta-analysisn = 49 studies
Pingeon et al. Safety of advanced therapies during pregnancy in women with immune-mediated inflammatory diseases: a systematic review and meta-analysis

Sign in to react

Enter your email and we send a 6-digit code and a link. No password.

Your name and role

These appear beside any methods concern you post and on your profile page.